Kinsale Capital Partners
500 W. Madison St., Suite 1000, Chicago, Illinois, 60661, United States
Overview
Kinsale must meet the following underwriting criteria before it will consider an investment: The capital needs are for growth, restructuring, ownership transition, or special situations. Assets are significantly undervalued or underperforming. They, as well as the company's advisory team, must have knowledge, experience, or special insight into the industry or market in which the company competes. With the help of their investor partners, they acquire businesses. Capital is provided by private placements or by partnering with appropriate investors. When necessary, the management or industry expertise is brought to the table.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Financial Services
- Venture Capital
Investment portfolio
- GeneriCo
Led · Series A · Aug 2015
GeneriCo develops and markets niche generic pharmaceuticals built around unique drug delivery formats and formulations. The company is led by President and CEO Tom Brya and is based in St. Louis, MO. Its pipeline includes 22 potential drug formulations and contract distribution rights for several additional drugs. GeneriCo plans to use the newly raised capital to expand operations over the next 18 months. The company also anticipates raising a Series B round in Q3 2016. Current financing activity suggests the firm is in an early commercial/scale-up phase, investing proceeds to grow operations and advance its pipeline.
Team
No current team members are available.